Skip to main content

Advertisement

Log in

Value of the identification of microsatellite instability in colorectal cancer

  • Research Articles
  • Published:
Clinical and Translational Oncology Aims and scope Submit manuscript

Abstract

Objective

Recent studies defend a possible prognostic and therapeutic value of the identification of microsatellite instability (MSI) in colorectal cancer. This work tries to assess the impact that the identification of MSI tumours can have in clinical practice.

Material and methods

We recovered tumour samples from 92 of the 143 patients operated on for colorectal cancer in our institution between 1995 and 2000. Five MSI markers (BAT 25, BAT 26, D2S123, D5S346 and D17S250) were studied on them. The rate and clinicopathologic characteristics of MSI tumours were investigated along with their impact on the global and disease-free survival as compared with microsatellite stable (MSS) tumours.

Results

All 5 microsatellite markers’ status were established in 73 patients (79.3% of the samples). Among them, 7 tumours showed instability in just one marker (low microsatellite instability [MSI-L]) whereas 5 tumours had mutations in 2 or more markers (high microsatellite instability [MSI-H]), for a total 15.4% rate of MSI tumours. All MSI-H tumours were located in the right colon. We could not find any impact from MSI detection on global or disease-free survival.

Conclusions

MSI determination did not identify groups of patients with a different prognosis. Moreover, with such low incidence its determination can only be justified in those cases that fulfill Bethesda’s criteria to identify families with Lynch’s syndrome.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Similar content being viewed by others

References

  1. Rodriguez-Bigas MA, Boland CR, Hamilton SR et al (1998) A National Cancer Institute Workshop on Hereditary Nonpolyposis Colorectal Cancer Syndrome: meeting highlights and Bethesda guidelines. J Natl Cancer Inst 89:1758–1762. Comment in: J Natl Cancer Inst 1998;90:939–940

    Article  Google Scholar 

  2. Perucho M (1996) Cancer of the microsatellite mutator phenotype. Biol Chem 377:675–684

    PubMed  CAS  Google Scholar 

  3. Sinicrope FA, Rego RL, Foster N et al (2006) Microsatellite instability accounts for tumour site-related differences in clinicopathologic variables and prognosis in human colon cancers. Am J Gastroenterol 101:2818–2825

    Article  PubMed  CAS  Google Scholar 

  4. Jo WS, Carethers JM (2006) Chemotherapeutic implications in microsatellite unstable colorectal cancer. Cancer Biomark 2:51–60

    PubMed  CAS  Google Scholar 

  5. Casado E, De Castro J, Belda-Iniesta C et al (2007) Molecular markers in colorectal cancer: genetic bases for a customised treatment. Clin Transl Oncol 9:549–554

    Article  PubMed  CAS  Google Scholar 

  6. Umetani N, Sasaki S, Watanabe T et al (2000) Diagnostic primer sets for microsatellite instability optimized for a minimal amount of damaged DNA from colorectal tissue samples. Ann Surg Oncol 7:276–280

    Article  PubMed  CAS  Google Scholar 

  7. Marsoni S (2001) International Multicenter Pooled Analysis of Colon Cancer Trials Investigators. Efficacy of adjuvant fluorouracil and leucovorin in stage B2 and C colon cancer. International Multicenter Pooled Analysis of Colon Cancer Trials Investigators. Semin Oncol 28[1 Suppl 1]:14–19

    Article  PubMed  CAS  Google Scholar 

  8. Wolmark N, Colangelo L, Wieand S (2001) National Surgical Adjuvant Breast and Bowel Project trials in colon cancer. Semin Oncol 28[1 Suppl 1]:9–13

    Article  PubMed  CAS  Google Scholar 

  9. Aranda E, Abad A, Carrato A et al; TTD Group (2006) Guides for adjuvant treatment of colon cancer. TTD Group (Spanish Cooperative Group for Gastrointestinal Tumour Therapy). Clin Transl Oncol 8:98–102

    Article  PubMed  CAS  Google Scholar 

  10. Chang SC, Lin JK, Yang SH et al (2006) Relationship between genetic alterations and prognosis in sporadic colorectal cancer. Int J Cancer 118:1721–1727

    Article  PubMed  CAS  Google Scholar 

  11. Lim SB, Jeong SY, Lee MR et al (2004) Prognostic significance of microsatellite instability in sporadic colorectal cancer. Int J Colorectal Dis 19:533–537

    Article  PubMed  Google Scholar 

  12. Ward RL, Cheong K, Ku SL et al (2003) Adverse prognostic effect of methylation in colorectal cancer is reversed by microsatellite instability. J Clin Oncol 21:3729–3736

    Article  PubMed  CAS  Google Scholar 

  13. Bubb VJ, Curtis LJ, Cunningham C et al (1996) Microsatellite instability and the role of hMSH2 in sporadic colorectalcancer. Oncogene 12:2641–2649

    PubMed  CAS  Google Scholar 

  14. Chen WS, Chen JY, Liu JM et al (1997) Microsatellite instability in sporadic-colon-cancer patients with and without liver metastases. Int J Cancer 74:470–474

    Article  PubMed  CAS  Google Scholar 

  15. Halling KC, French AJ, McDonnell SK et al (1999) Microsatellite instability and 8p allelic imbalance in stage B2 and C colorectal cancers. J Natl Cancer Inst 91:1295–1303

    Article  PubMed  CAS  Google Scholar 

  16. Sinicrope FA, Rego RL, Halling KC et al (2006) Prognostic impact of microsatellite instability and DNA ploidy in human colon carcinoma patients. Gastroenterology 131:729–737

    Article  PubMed  CAS  Google Scholar 

  17. Lanza G, Gafà R, Santini A et al (2006) Immunohistochemical test for MLH1 and MSH2 expression predicts clinical outcome in stage II and III colorectal cancer patients. J Clin Oncol 24:2359–2367

    Article  PubMed  CAS  Google Scholar 

  18. Westra JL, Plukker JT, Buys CH, Hofstra RM (2004) Genetic alterations in locally advanced stage II/III colon cancer: a search for prognostic markers. Clin Colorectal Cancer 4:252–259

    Article  PubMed  CAS  Google Scholar 

  19. Benatti P, Gafà R, Barana D et al (2005) Microsatellite instability and colorectal cancer prognosis. Clin Cancer Res 11:8332–8340. Erratum in: Clin Cancer Res 2006;12:3868–3869

    Article  PubMed  CAS  Google Scholar 

  20. Carethers JM, Smith EJ, Behling CA et al (2004) Use of 5-fluorouracil and survival in patients with microsatellite-unstable colorectal cancer. Gastroenterology 126:394–401

    Article  PubMed  CAS  Google Scholar 

  21. Jover R, Zapater P, Castells A et al; Gastrointestinal Oncology Group of the Spanish Gastroenterological Association (2006) Mismatch repair status in the prediction of benefit from adjuvant fluorouracil chemotherapy in colorectal cancer. Gut 55:848–855

    Article  PubMed  CAS  Google Scholar 

  22. Ricciardiello L, Ceccarelli C, Angiolini G et al (2005) High thymidylate synthase expression in colorectal cancer with microsatellite instability: implications for chemotherapeutic strategies. Clin Cancer Res 11:4234–4240

    Article  PubMed  CAS  Google Scholar 

  23. Lamberti C, Lundin S, Bogdanow M et al (2007) Microsatellite instability did not predict individual survival of unselected patients with colorectal cancer. Int J Colorectal Dis 22:145–152

    Article  PubMed  CAS  Google Scholar 

  24. Wang C, van Rijnsoever M, Grieu F et al (2003) Prognostic significance of microsatellite instability and Ki-ras mutation type in stage II colorectal cancer. Oncology 64:259–265

    Article  PubMed  CAS  Google Scholar 

  25. Westra JL, Schaapveld M, Hollema H et al (2005) Determination of TP53 mutation is more relevant than microsatellite instability status for the prediction of disease-free survival in adjuvant-treated stage III colon cancer patients. J Clin Oncol 23:5635–5643

    Article  PubMed  CAS  Google Scholar 

  26. Malesci A, Laghi L, Bianchi P et al (2007) Reduced likelihood of metastases in patients with microsatellite-unstable colorectal cancer. Clin Cancer Res 13:3831–3839

    Article  PubMed  CAS  Google Scholar 

  27. Hemminki A, Mecklin JP, Järvinen H et al (2000) Microsatellite instability is a favorable prognostic indicator in patients with colorectal cancer receiving chemotherapy. Gastroenterology 119:921–928

    Article  PubMed  CAS  Google Scholar 

  28. Elsaleh H, Powell B, McCaul K et al (2001) P53 alteration and microsatellite instability have predictive value for survival benefit from chemotherapy in stage III colorectal carcinoma. Clin Cancer Res 7:1343–1349

    PubMed  CAS  Google Scholar 

  29. Watanabe T, Wu TT, Catalano PJ et al (2001) Molecular predictors of survival after adjuvant chemotherapy for colon cancer. N Engl J Med 344:1196–1206

    Article  PubMed  CAS  Google Scholar 

  30. Ribic CM, Sargent DJ, Moore MJ et al (2003) Tumour microsatellite-instability status as a predictor of benefit from fluorouracil-based adjuvant chemotherapy for colon cancer. N Engl J Med 349:247–257

    Article  PubMed  CAS  Google Scholar 

  31. Barratt PL, Seymour MT, Stenning SP et al; UKCCCR AXIS trial collaborators (2002) Adjuvant X-ray and Fluorouracil Infusion Study. DNA markers predicting benefit from adjuvant fluorouracil in patients with colon cancer: a molecular study. Lancet 360:1381–1391

    Article  PubMed  CAS  Google Scholar 

  32. Storojeva I, Boulay JL, Heinimann K et al (2005) Prognostic and predictive relevance of microsatellite instability in colorectal cancer. Oncol Rep 14:241–249

    PubMed  CAS  Google Scholar 

  33. Kim GP, Colangelo LH, Wieand HS et al; National Cancer Institute (2007) Prognostic and predictive roles of high-degree microsatellite instability in colon cancer: a National Cancer Institute-National Surgical Adjuvant Breast and Bowel Project Collaborative Study. J Clin Oncol 25:767–772

    Article  PubMed  CAS  Google Scholar 

  34. Popat S, Hubner R, Houlston RS (2005) Systematic review of microsatellite instability and colorectal cancer prognosis. J Clin Oncol 23:609–618

    Article  PubMed  CAS  Google Scholar 

  35. des Guetz G, Mariani P, Cucherousset J et al (2007) Microsatellite instability and sensitivitiy to FOLFOX treatment in metastatic colorectal cancer. Anticancer Res 27:2715–2719

    PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Antonio Barrasa Shaw.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Barrasa Shaw, A., López-Guerrero, J.A., Calatrava Fons, A. et al. Value of the identification of microsatellite instability in colorectal cancer. Clin Transl Oncol 11, 465–469 (2009). https://doi.org/10.1007/s12094-009-0386-y

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s12094-009-0386-y

Keywords

Navigation